I like it clik - slow, steady, patient climb at say 4% per day maximum for 100 trading days would take us to around 20 cents without any of the parasites and bottom feeders lurking about . . . I'd be happy with a year or two or three . . . because that's where BIEL is going . . .
BIEL ActiPatch, UK NHS Tariff - USA FDA OTC Clearance for retail and at least 4, yep, count 'em, 4 Co-Branding deals in the USA with multi-national Big Boys . . . . let's see. . . . .
(i) Bayer/Dr. Scholl's waiting for the agreement and there is none better than Bayer/Dr. Scholl's for highly competent management; read the Bayer global annual report - absolutely first class company;
(ii) B. Braun for RecoveryRx expanded marketing and sales in the UK, EU (and although unannounced, presumably USA) announced April 15. I will wager that deal is done because Braun is an amazing company to work with - do the DD - how many countries? How many sales Reps and employees and how many billions in sales? Remember the second FDA meeting later in May is about RecoveryRx post-surgery and Braun is all about RecoverryRx post-surgery . . . . hmmmmm;
(iii) Not telling; and
(iv) Not telling . . . . all imminent
News 
Market Data 
Discover 
